Heartflow, Inc.

HTFL Nasdaq SEC CIK 1464521
Follow Heartflow Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $72.9M +57.4% vs same quarter last year
Net income −$11.5M +77.4% vs same quarter last year
EPS, diluted −$0.13 +87.5% vs same quarter last year
Operating cash flow $323K +110.9% vs same quarter last year
Revenue by quarter
$35M
$37.2M
$43.4M
$46.3M
$49.1M
$52.6M
$64.1M
$72.9M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income4 fiscal years
  • Revenue
  • Net income
−$200M−$100M$0$100M$200MFY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$176M−$116.8M
FY24$125.8M−$96.4M
FY23$87.2M−$95.7M
FY22--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−150%−100%−50%0%50%100%FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2576.8%−36.4%−66.3%
FY2475.1%−48.7%−76.6%
FY2366.6%−83.6%−109.7%
FY22---
Free cash flowOperating cash flow minus capital expenditure
−$100M−$75M−$50M−$25M$0FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$59M
FY24−$73.4M
FY23−$82.5M
FY22-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Heartflow
  • Healthcare median
−150%−100%−50%0%FY22FY23FY24FY25
Show the numbers
YearHeartflowHealthcare median
FY25−66.3%−30.6%
FY24−76.6%−47%
FY23−109.7%−58%
FY22-−80.4%